OrthoPediatrics Statistics
Total Valuation
OrthoPediatrics has a market cap or net worth of $534.87 million. The enterprise value is $546.93 million.
Important Dates
The next confirmed earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OrthoPediatrics has 24.83 million shares outstanding. The number of shares has increased by 1.77% in one year.
| Current Share Class | 24.83M |
| Shares Outstanding | 24.83M |
| Shares Change (YoY) | +1.77% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 4.91% |
| Owned by Institutions (%) | 68.68% |
| Float | 16.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.43 |
| Forward PS | 2.20 |
| PB Ratio | 1.47 |
| P/TBV Ratio | 2.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.98, with a Debt / Equity ratio of 0.23.
| Current Ratio | 6.98 |
| Quick Ratio | 3.27 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.26 |
Financial Efficiency
Return on equity (ROE) is -10.34% and return on invested capital (ROIC) is -4.48%.
| Return on Equity (ROE) | -10.34% |
| Return on Assets (ROA) | -4.05% |
| Return on Invested Capital (ROIC) | -4.48% |
| Return on Capital Employed (ROCE) | -6.72% |
| Revenue Per Employee | $364,283 |
| Profits Per Employee | -$67,299 |
| Employee Count | 562 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 0.50 |
Taxes
| Income Tax | -4.11M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.25% in the last 52 weeks. The beta is 1.17, so OrthoPediatrics's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -31.25% |
| 50-Day Moving Average | 23.61 |
| 200-Day Moving Average | 26.17 |
| Relative Strength Index (RSI) | 43.45 |
| Average Volume (20 Days) | 168,239 |
Short Selling Information
The latest short interest is 1.12 million, so 4.51% of the outstanding shares have been sold short.
| Short Interest | 1.12M |
| Short Previous Month | 1.02M |
| Short % of Shares Out | 4.51% |
| Short % of Float | 6.70% |
| Short Ratio (days to cover) | 6.65 |
Income Statement
In the last 12 months, OrthoPediatrics had revenue of $204.73 million and -$37.82 million in losses. Loss per share was -$1.64.
| Revenue | 204.73M |
| Gross Profit | 148.60M |
| Operating Income | -29.52M |
| Pretax Income | -27.03M |
| Net Income | -37.82M |
| EBITDA | -10.44M |
| EBIT | -29.52M |
| Loss Per Share | -$1.64 |
Full Income StatementBalance Sheet
The company has $68.83 million in cash and $80.90 million in debt, giving a net cash position of -$12.06 million or -$0.49 per share.
| Cash & Cash Equivalents | 68.83M |
| Total Debt | 80.90M |
| Net Cash | -12.06M |
| Net Cash Per Share | -$0.49 |
| Equity (Book Value) | 354.57M |
| Book Value Per Share | 14.64 |
| Working Capital | 203.21M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$27.05 million and capital expenditures -$14.26 million, giving a free cash flow of -$41.31 million.
| Operating Cash Flow | -27.05M |
| Capital Expenditures | -14.26M |
| Free Cash Flow | -41.31M |
| FCF Per Share | -$1.66 |
Full Cash Flow StatementMargins
Gross margin is 72.58%, with operating and profit margins of -14.42% and -18.47%.
| Gross Margin | 72.58% |
| Operating Margin | -14.42% |
| Pretax Margin | -20.48% |
| Profit Margin | -18.47% |
| EBITDA Margin | -5.10% |
| EBIT Margin | -14.42% |
| FCF Margin | n/a |
Dividends & Yields
OrthoPediatrics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.77% |
| Shareholder Yield | n/a |
| Earnings Yield | -7.07% |
| FCF Yield | -7.72% |
Analyst Forecast
The average price target for OrthoPediatrics is $36.67, which is 70.24% higher than the current price. The consensus rating is "Buy".
| Price Target | $36.67 |
| Price Target Difference | 70.24% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OrthoPediatrics has an Altman Z-Score of 3.48 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.48 |
| Piotroski F-Score | 3 |